We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EBC icon
3476
Eastern Bankshares
EBC
$5.25B
$2.63M ﹤0.01%
188,044
-59,114
-24% -$785K
KNTK icon
3477
Kinetik
KNTK
$8.32B
$2.63M ﹤0.01%
63,411
-8,486
-12% -$337K
CPRX
3478
DELISTED
Catalyst Pharmaceutical
CPRX
$2.62M ﹤0.01%
169,391
-219,708
-56% -$3.42M
IVZ icon
3479
PUT
Invesco
IVZ
$14B
$2.62M ﹤0.01%
175,000
-348,000
-67% -$5.35M
SPIP icon
3480
State Street SPDR Portfolio TIPS ETF
SPIP
$1.01B
$2.62M ﹤0.01%
102,963
+4,477
+5% +$113K
CHX
3481
CALL
DELISTED
ChampionX
CHX
$2.62M ﹤0.01%
78,800
-150,000
-66% -$5.12M
DFS
3482
PUT
DELISTED
Discover Financial Services
DFS
$2.62M ﹤0.01%
20,000
VIR icon
3483
Vir Biotechnology
VIR
$1.5B
$2.61M ﹤0.01%
293,475
-172,733
-37% -$1.66M
GVLU icon
3484
Gotham 1000 Value ETF
GVLU
$295M
$2.61M ﹤0.01%
114,017
+26,653
+31% +$616K
NUHY icon
3485
Nuveen ESG High Yield Corporate Bond ETF
NUHY
$111M
$2.61M ﹤0.01%
124,691
+81,876
+191% +$1.71M
REI icon
3486
Ring Energy
REI
$354M
$2.61M ﹤0.01%
1,541,855
+507,974
+49% +$934K
ONT
3487
Onterris Inc
ONT
$546M
$2.61M ﹤0.01%
58,475
-15,079
-21% -$678K
DTH icon
3488
WisdomTree International High Dividend Fund
DTH
$660M
$2.61M ﹤0.01%
67,889
-114,284
-63% -$4.54M
PIO icon
3489
Invesco Global Water ETF
PIO
$280M
$2.61M ﹤0.01%
64,476
-16,023
-20% -$666K
DKL icon
3490
Delek Logistics
DKL
$3.15B
$2.6M ﹤0.01%
64,152
-22,753
-26% -$895K
RWT
3491
Redwood Trust
RWT
$574M
$2.59M ﹤0.01%
399,726
-12,676
-3% -$78.8K
HEEM icon
3492
iShares Currency Hedged MSCI Emerging Markets
HEEM
$286M
$2.59M ﹤0.01%
95,618
+11,427
+14% +$302K
TTMI icon
3493
TTM Technologies
TTMI
$13.7B
$2.59M ﹤0.01%
133,174
+36,328
+38% +$620K
SMTC icon
3494
Semtech
SMTC
$12.2B
$2.59M ﹤0.01%
86,596
+39,456
+84% +$1.38M
PLAY icon
3495
Dave & Buster's
PLAY
$343M
$2.59M ﹤0.01%
64,955
+39,861
+159% +$2.07M
APA icon
3496
CALL
APA Corp
APA
$14.4B
$2.58M ﹤0.01%
87,800
XRN
3497
Chiron Real Estate Inc
XRN
$475M
$2.58M ﹤0.01%
56,906
+4,786
+9% +$208K
CBU icon
3498
Community Bank
CBU
$3.37B
$2.58M ﹤0.01%
54,621
+3,903
+8% +$177K
AIN icon
3499
Albany International
AIN
$1.73B
$2.58M ﹤0.01%
30,497
-16
-0.1% -$1.4K
BECN
3500
DELISTED
Beacon Roofing Supply, Inc.
BECN
$2.58M ﹤0.01%
28,458
-63,460
-69% -$6.12M

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.